These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 22664229)

  • 1. Advancing risk assessment of engineered nanomaterials: application of computational approaches.
    Gajewicz A; Rasulev B; Dinadayalane TC; Urbaszek P; Puzyn T; Leszczynska D; Leszczynski J
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1663-93. PubMed ID: 22664229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation criteria for the quality of published experimental data on nanomaterials and their usefulness for QSAR modelling.
    Lubinski L; Urbaszek P; Gajewicz A; Cronin MT; Enoch SJ; Madden JC; Leszczynska D; Leszczynski J; Puzyn T
    SAR QSAR Environ Res; 2013; 24(12):995-1008. PubMed ID: 24313439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the toxicity of selected types of nanochemicals.
    Kumar V; Kumari A; Guleria P; Yadav SK
    Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risks associated with nanotechnology based on European Union legislation].
    Hydzik P
    Przegl Lek; 2012; 69(8):490-1. PubMed ID: 23243915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers.
    Simeonova PP; Erdely A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():68-73. PubMed ID: 19558236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC; Kanarek MS
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's new in nanotoxicology? Implications for public health from a brief review of the 2008 literature.
    Boczkowski J; Hoet P
    Nanotoxicology; 2010 Mar; 4(1):1-14. PubMed ID: 20795899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology safety concerns revisited.
    Stern ST; McNeil SE
    Toxicol Sci; 2008 Jan; 101(1):4-21. PubMed ID: 17602205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure assessment approaches for engineered nanomaterials.
    Abbott LC; Maynard AD
    Risk Anal; 2010 Nov; 30(11):1634-44. PubMed ID: 20626687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational tool for risk assessment of nanomaterials: novel QSTR-perturbation model for simultaneous prediction of ecotoxicity and cytotoxicity of uncoated and coated nanoparticles under multiple experimental conditions.
    Kleandrova VV; Luan F; González-Díaz H; Ruso JM; Speck-Planche A; Cordeiro MN
    Environ Sci Technol; 2014 Dec; 48(24):14686-94. PubMed ID: 25384130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling approaches for characterizing and evaluating environmental exposure to engineered nanomaterials in support of risk-based decision making.
    Hendren CO; Lowry M; Grieger KD; Money ES; Johnston JM; Wiesner MR; Beaulieu SM
    Environ Sci Technol; 2013 Feb; 47(3):1190-205. PubMed ID: 23293982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
    Lai DY
    Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment?
    Moore MN
    Environ Int; 2006 Dec; 32(8):967-76. PubMed ID: 16859745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotoxicology and in vitro studies: the need of the hour.
    Arora S; Rajwade JM; Paknikar KM
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):151-65. PubMed ID: 22178382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nanoparticles (part 2)--advantages and health risk].
    Swidwińska-Gajewska AM
    Med Pr; 2007; 58(3):253-63. PubMed ID: 17926516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health--lessons learned from four case studies.
    Aschberger K; Micheletti C; Sokull-Klüttgen B; Christensen FM
    Environ Int; 2011 Aug; 37(6):1143-56. PubMed ID: 21397332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.